Premila Bhat, MD
Nephrology · College Point, NYNPI 1083818546
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,305 of the $1,890 with a category attached, or 69.0%. 15 manufacturers reported payments, led by Vantive US Healthcare LLC at 44.7% of the total. 2025 is the largest year on record at $888, 5.2 times the $172 reported in 2019.
Across 46 payments — averaging $41.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vantive US Healthcare LLC$845
- Johnson & Johnson$263
- AbbVie$215
- GSK$103
- EMD Serono, Inc.$86
- Gilead$77
- plus $302 from 9 others
Across 17 payments — averaging $4468.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$76K
What the payments were for
- Travel & lodging$57230%
- Food & beverage$1,30569%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vantive US Healthcare LLC | 10 | $845 |
| Johnson & Johnson | 9 | $263 |
| AbbVie | 10 | $215 |
| GSK | 1 | $103 |
| EMD Serono, Inc. | 1 | $86 |
| Gilead | 3 | $77 |
| Shire North American Group Inc | 3 | $74 |
| Gastroklenz, Inc. DBA Cloudcath | 1 | $57 |
| Insmed, Inc. | 1 | $36 |
| Dynavax Technologies Corporation | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Melinta Therapeutics, LLC | 1 | $24 |
| Renalytix AI, Inc. | 1 | $23 |
| Akebia Therapeutics Inc | 1 | $21 |
| Rockwell Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Renal - Chronic$693
- BENLYSTA$103
How this compares
$1,890 in reported general payments places this provider in the 65th percentile of 935 nephrology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 64 | $59,749 |
| KerendiaFinerenone | 69 | $57,382 |
| JardianceEmpagliflozin | 66 | $55,680 |
| VeltassaPatiromer Calcium Sorbitex | 28 | $39,088 |
| LokelmaSodium Zirconium Cyclosilicate | 16 | $14,145 |
| Calcitriol | 21 | $514 |
| Losartan Potassium | 23 | $157 |
| Desmopressin Acetate | 12 | $94 |
| Amlodipine Besylate | 18 | $82 |
| Clonidine Hcl | 11 | $49 |
| Furosemide | 11 | $14 |
Paid to pharmacies, not to this prescriber.
Other nephrology in College Point
- Payam ShakouriPoughkeepsie$930K
- Gerald AppelNew York$842K
- Richard ChanNew York$514K
- Bruce SpinowitzBronx$465K
- Steven CocaNew York$445K
- Joseph RoglieriTroy$425K
- Jai RadhakrishnanNew York$369K
- Savneek ChughHawthorne$325K
- Gerard TepedinoManhasset$308K
- Frank CortazarAlbany$289K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.